Fujian Aonong Biological Technology Group Incorporation Limited
SSE:603363.SS
3.77 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||
| Net Income
| 63.092 | -3,768.684 | -1,226.951 | -1,850.92 | 993.605 | 100.356 | 10.242 | 122.077 | 108.35 | 38.689 | 39.221 | 24.991 |
| Depreciation & Amortization
| 832.545 | 1,234.745 | 1,289.628 | 1,042.46 | 327.214 | 155.436 | 105.058 | 72.876 | 51.719 | 33.545 | 16.8 | 0 |
| Deferred Income Tax
| 0 | 0 | -103.267 | -0.134 | -46.194 | -35.185 | -6.064 | -2.835 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | -4.393 | 19.244 | 9.895 | 42.046 | 7.312 | 10.353 | 0 | 0 | 53.012 | 6.307 | 0 |
| Change In Working Capital
| -498.95 | 1,822.521 | -577.207 | 203.403 | -1,319.441 | -39.922 | -224.481 | -227.805 | -73.625 | -30.387 | -117.359 | 0 |
| Accounts Receivables
| -3,695.223 | -301.328 | -47.361 | -146.699 | -325.202 | -64.047 | -189.516 | -144.944 | -34.485 | 0 | 0 | 0 |
| Inventory
| 455.309 | 2,072.869 | -1,223.489 | -1,289.648 | -1,449.423 | -257.265 | -64.636 | -105.007 | -42.977 | 1.442 | -9.763 | 0 |
| Accounts Payables
| 0 | -15.195 | 796.91 | 1,639.884 | 501.378 | 316.575 | 35.736 | 24.98 | 0 | 0 | 0 | 0 |
| Other Working Capital
| 2,740.964 | 66.175 | -103.267 | -0.134 | -46.194 | -35.185 | -159.845 | -122.798 | -30.648 | -31.829 | -107.597 | 0 |
| Other Non Cash Items
| -513.468 | 1,699.818 | 1,262.19 | 1,119.587 | 408.793 | 206.162 | 136.442 | 59.628 | 42.509 | 87.39 | 27.676 | -24.991 |
| Operating Cash Flow
| -116.781 | 984.007 | 663.637 | 524.291 | 406.023 | 394.159 | 27.261 | 26.776 | 128.952 | 129.238 | -33.663 | 0 |
| Investing Activities: | ||||||||||||
| Investments In Property Plant And Equipment
| -262.682 | -511.774 | -1,498.945 | -2,708.606 | -3,292.548 | -658.442 | -569.16 | -440.186 | -275.791 | -206.249 | -156.68 | -72.751 |
| Acquisitions Net
| 40.245 | 195.296 | -61.767 | -63.35 | -468.257 | -33.606 | -9.178 | -8.312 | -28.965 | -5.465 | 0 | 0 |
| Purchases Of Investments
| 0 | -1.678 | -107.531 | -19.756 | -167.786 | -24.2 | -55.337 | -114.339 | -13.7 | -7.74 | -4.85 | -7 |
| Sales Maturities Of Investments
| 28.594 | 5.58 | 9.125 | 1.031 | 4.3 | 0.234 | 101.149 | 0.112 | 1.2 | 0.04 | 0 | 0 |
| Other Investing Activites
| 154.769 | 37.649 | -44.095 | -15.671 | -77.924 | -11.141 | -14.516 | -2.8 | -2.338 | 1.633 | 2.065 | 0.005 |
| Investing Cash Flow
| -39.075 | -274.925 | -1,703.213 | -2,806.352 | -4,002.215 | -727.155 | -547.042 | -565.526 | -319.593 | -217.782 | -159.464 | -79.746 |
| Financing Activities: | ||||||||||||
| Debt Repayment
| -370.048 | -204.034 | 127.842 | 1,734.279 | 2,486.177 | 222.855 | 484.711 | 343.775 | 125.075 | 31.35 | 119 | 33.5 |
| Common Stock Issued
| 0 | 0 | 61.823 | 3.113 | 12.362 | 11.5 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | -8.442 | -61.823 | -3.113 | -12.362 | -11.5 | -0.712 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -76.392 | -294.864 | -373.665 | -102.821 | -51.783 | -10.855 | -73.677 | -26.12 | -17.78 | -42.789 | -11.859 | -4.201 |
| Other Financing Activities
| 1,581.929 | -678.717 | 1,527.822 | 811.126 | 1,624.805 | 276.37 | 50.316 | 268.977 | 40.784 | 176.884 | 43.681 | -7.6 |
| Financing Cash Flow
| 1,135.49 | -1,177.615 | 1,220.175 | 2,199.634 | 3,924.897 | 403.602 | 461.35 | 586.632 | 148.079 | 186.456 | 150.822 | 21.699 |
| Other Information: | ||||||||||||
| Effect Of Forex Changes On Cash
| 0.004 | -2.056 | -2.053 | -0.115 | -0.226 | 0.141 | 0.002 | 0 | -0 | 0 | 0 | 0 |
| Net Change In Cash
| 979.639 | -470.459 | 178.546 | -82.542 | 328.479 | 70.748 | -58.429 | 47.882 | -42.562 | 97.912 | -42.305 | 79.216 |
| Cash At End Of Period
| 1,131.688 | 152.049 | 622.508 | 443.962 | 526.504 | 198.025 | 127.278 | 185.706 | 137.824 | 180.386 | 82.474 | 124.779 |